Biobizkaia
Research center
University of Bristol
Brístol, Reino UnidoPublications in collaboration with researchers from University of Bristol (28)
2024
-
BEST-CLI International Collaborative: planning a better future for patients with chronic limb-threatening ischaemia globally
British Journal of Surgery, Vol. 111, Núm. 2
-
Update on ocular manifestations of the main monogenic and polygenic autoinflammatory diseases
Frontiers in Ophthalmology, Vol. 4
2022
-
Validation of the OAKS prognostic model for acute kidney injury after gastrointestinal surgery
BJS Open, Vol. 6, Núm. 1
2021
-
Mapping the human genetic architecture of COVID-19
Nature, Vol. 600, Núm. 7889, pp. 472-477
2020
-
Corrigendum to ‘Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia’ (European Journal of Vascular & Endovascular Surgery (2019) 58(1S) (S1–S109.e33), (S1078588419303806), (10.1016/j.ejvs.2019.05.006))
European Journal of Vascular and Endovascular Surgery
-
Corrigendum to “Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischaemia” [Eur J Vasc Endovasc Surg 58 (1S) (2019) 1–109>] (European Journal of Vascular & Endovascular Surgery (2019) 58(1S) (S1–S109.e33), (S1078588419303806), (10.1016/j.ejvs.2019.05.006))
European Journal of Vascular and Endovascular Surgery
2019
-
Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia
European Journal of Vascular and Endovascular Surgery, Vol. 58, Núm. 1, pp. S1-S109.e33
2018
-
Editor's Choice – Management of Atherosclerotic Carotid and Vertebral Artery Disease: 2017 Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS)
European Journal of Vascular and Endovascular Surgery, Vol. 55, Núm. 1, pp. 3-81
-
Guidance on Noncorticosteroid Systemic Immunomodulatory Therapy in Noninfectious Uveitis: Fundamentals Of Care for UveitiS (FOCUS) Initiative
Ophthalmology, Vol. 125, Núm. 5, pp. 757-773
-
The Tatton-Brown-Rahman Syndrome: A clinical study of 55 individuals with de novo constitutive DNMT3A variants [version 1; referees: 3 approved]
Wellcome Open Research, Vol. 3
2017
-
Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study
The Lancet Neurology, Vol. 16, Núm. 4, pp. 271-281
2016
2015
-
Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013
The Lancet, Vol. 385, Núm. 9963, pp. 117-171
-
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013
The Lancet, Vol. 386, Núm. 10010, pp. 2287-2323
-
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: Quantifying the epidemiological transition
The Lancet, Vol. 386, Núm. 10009, pp. 2145-2191
-
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013
The Lancet, Vol. 386, Núm. 9995, pp. 743-800
2014
-
Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease
Nature Genetics, Vol. 46, Núm. 9, pp. 989-993
2013
-
Ethanol reversal of cellular tolerance to morphine in rat locus coeruleus neurons
Molecular Pharmacology, Vol. 84, Núm. 2, pp. 252-260